ArticleTrials2019

Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1genotyping in previous treated metastatic colorectal cancer patients:study protocol for a randomized controlled trial.

Cheng-Jen Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.